Shaun Stewart

Shaun Stewart has a wealth of experience in the field of antibody discovery and engineering. Shaun began their career in 2012 as a Presidential Postdoctoral Fellow at Novartis. In 2014, they moved to Pfizer as a Senior Scientist in Technology Development. In 2016, they joined Incyte as a Director of Antibody Discovery, later becoming Associate Director and Principal Investigator of Antibody Biotherapeutics. In 2022, they began their current role as Executive Director and Head of Antibody Discovery and Engineering at Resonant Therapeutics.

Shaun Stewart received their Ph.D. in Microbiology from Washington University in St. Louis and their B.A. with Honors in Biology from the University of Pennsylvania.